0
Her har der også været nogle pæne insiderkøb
This company is working on HSP90 inhibitors, (Ganetespib) which has shown up to 100 times greater potency in killing cancer cells and an improved safety profile when compared to other treatments.
http://finance.yahoo.com/q?s=snta&ql=1
P 2011-04-14 2011-04-18 16:10:42 SYNTA PHARMACEUTICALS CORP SNTA WILSON ROBERT N director 50,000 $4.89
P 2011-04-14 2011-04-18 16:06:15 SYNTA PHARMACEUTICALS CORP SNTA Gollust Keith R director 100,000 $4.89
P 2011-04-14 2011-04-18 16:05:55 SYNTA PHARMACEUTICALS CORP SNTA Kovner Bruce director 10% owner 1,431,493 $4.89
This company is working on HSP90 inhibitors, (Ganetespib) which has shown up to 100 times greater potency in killing cancer cells and an improved safety profile when compared to other treatments.
http://finance.yahoo.com/q?s=snta&ql=1
P 2011-04-14 2011-04-18 16:10:42 SYNTA PHARMACEUTICALS CORP SNTA WILSON ROBERT N director 50,000 $4.89
P 2011-04-14 2011-04-18 16:06:15 SYNTA PHARMACEUTICALS CORP SNTA Gollust Keith R director 100,000 $4.89
P 2011-04-14 2011-04-18 16:05:55 SYNTA PHARMACEUTICALS CORP SNTA Kovner Bruce director 10% owner 1,431,493 $4.89
